| GEN
Genesis Research & Development Corporation Ltd
Description:
* "Founded
in 1994, Genesis Research and Development Corporation Limited is one of
Australasia's largest publicly listed biotechnology companies. We operate
from the early discovery end of the spectrum to Phase II Clinical Trials
and have a proven and highly efficient research and development platform,
a growing pipeline of product candidates and a history of productive
collaborative partnerships."
Website: http://www.genesis.co.nz/
Recent announcements: click here
|
 |
Financials
|
Year
|
2002
|
2003
|
2004
|
2005
|
|
Average
GR
|
Compounding
GR
|
|
Gross
growth rates
|
|
|
|
|
|
Revenue
|
|
-36%
|
-56%
|
-42%
|
|
-106%
|
-30%
|
|
NPAT
|
|
19%
|
8%
|
-48%
|
|
-35%
|
-8%
|
|
Total
Assets
|
|
-36%
|
-50%
|
-52%
|
|
-111%
|
-31%
|
|
Net
Assets
|
|
-32%
|
-50%
|
-53%
|
|
-111%
|
-31%
|
|
Per
Share figures and growth
|
|
Earnings
|
$
(0.41)
|
$
(0.49)
|
$
(0.52)
|
$
(0.27)
|
|
|
|
|
|
|
19%
|
8%
|
-48%
|
|
-35%
|
-8%
|
|
Net
Assets
|
$
1.53
|
$
1.04
|
$
0.52
|
$
0.24
|
|
|
|
|
|
|
-32%
|
-50%
|
-53%
|
|
-111%
|
-31%
|
|
Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profitability
|
|
Return
on Assets
|
-23%
|
-43%
|
-93%
|
-101%
|
|
|
|
|
Equity
Multiplier
|
1.14
|
1.08
|
1.09
|
1.11
|
|
|
|
|
Return
on Equity (ROE)
|
-27%
|
-47%
|
-101%
|
-112%
|
|
|
|
|
ROE
(avg E)
|
|
-38%
|
-67%
|
-72%
|
|
|
|
|
Net
Profit Margin
|
-69%
|
-127%
|
-309%
|
-275%
|
|
|
|
|
Dividend
payout ratio
|
0%
|
0%
|
0%
|
0%
|
|
|
|
|
Liquidity
|
|
Net
working capital
|
$31,912,000
|
$21,577,000
|
$10,154,000
|
$4,544,000
|
|
|
|
|
Current
ratio
|
6.56
|
11.40
|
9.11
|
7.52
|
|
|
|
|
Acid
test ratio
|
6.56
|
11.40
|
9.11
|
7.52
|
|
|
|
|
Other
|
|
Times
interest earned
|
|
|
|
|
|
|
|
|
Operating
exp/income
|
169%
|
227%
|
409%
|
375%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary
Financials
|
|
Income
|
15523000
|
9968000
|
4433000
|
2592000
|
|
|
|
|
Expenses
|
26207000
|
22670000
|
18128000
|
9726000
|
|
|
|
|
Tax
|
0
|
0
|
0
|
0
|
|
|
|
|
NPAT
|
-10684000
|
-12702000
|
-13695000
|
-7134000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
45648000
|
29286000
|
14768000
|
7079000
|
|
|
|
|
Liabilities
|
5735000
|
2075000
|
1252000
|
697000
|
|
|
|
|
Net
Assets
|
39913000
|
27211000
|
13516000
|
6382000
|
|
|
|
|

|
Graphs
|
|
Company Directory
Registered Office:
One Fox Street
Parnell,
Auckland,
New Zealand |
Mailing address:
|
Directors:
J H von Roy
J N McLean
A J H Gearin g, PhD
S Gi llis, PhD
S J Washer, PhD
|
Secretary:
|
Auditors:
Ernst & Young
|
Solicitors:
New Zealand
Lowndes Jordan
Baldwins
Australia
Allens Arthur Robinson
United States of
America
Connolly Bove Lodge & Hutz LLP
Speckman Law Group |
Bankers:
|
Registrar:
Computershare Investor Services Limited
|
Other:
|
|
|
| Other |
Last updated: 14-11-2007
|
Company balance date: 31 December
Trading over the last year
|
|
| Company Endorsed Add-on section
|
|
| enquire about sponsorship
and advertising: info@smallcaps.co.nz
|
|